Yuxuan AN, Zongyi XIAO, Xiaoyan WANG, et al. Shared signaling pathway in pyroptosis and apoptosis in A549 cells induced by oxygen and glucose deprivation/recovery[J]. Journal of Army Medical University, 2022, 44(11): 1119-1125.
DOI:
Yuxuan AN, Zongyi XIAO, Xiaoyan WANG, et al. Shared signaling pathway in pyroptosis and apoptosis in A549 cells induced by oxygen and glucose deprivation/recovery[J]. Journal of Army Medical University, 2022, 44(11): 1119-1125. DOI: 10.16016/j.2097-0927.202112247.
Shared signaling pathway in pyroptosis and apoptosis in A549 cells induced by oxygen and glucose deprivation/recovery
To investigate the effects of oxygen and glucose deprivation/recovery (OGD/R) on apoptosis and pyroptosis of A549 cells
and to explore the possibility of the mutual regulation in apoptosis and pyroptosis.
Methods
2
A549 cells were resuscitated and cultured
randomly divided into control group
OGD/R group
OGD/R+pyroptosis inhibitor group (OGD/R+VX-765) and OGD/R+apoptosis inhibitor group (OGD/R+FMK). The apoptotic rate was detected by flow cytometry
the levels of pyroptosis markers IL-1β and IL-18 in the supernatant were measured by ELISA
and the expression of key molecules in pyroptosis and apoptosis at mRNA and protein levels were detected by RT-qPCR and Western blotting
respectively.
Results
2
The apoptotic rate was significantly increased in the OGD/R group than the control group (12.57±1.97
vs
3.67±0.64
P
<
0.05)
and the rate of the OGD/R+VX-765 group was decreased than that of the OGD/R group (5.97±1.28
P
<
0.05). OGD/R resulted in obvious increased levels of IL-1β and IL-18 in the supernatant (17.35±0.44
vs
7.80±0.80 ng/L
18.06±1.73
vs
7.99±0.11 ng/L
P
<
0.05)
but FMK treatment notably reversed the increases of 2 inflammatory factors (4.72±0.59
10.24±1.42 ng/L
P
<
0.05). OGD/R enhanced the mRNA and protein expression levels of key molecules of apoptosis and proptosis in A549 cells. While
VX-765 decreased the mRNA and protein levels of BID (1.12±0.18
vs
1.74±0.14
1.01±0.10
vs
1.29±0.09
P
<
0.05)
and FMK reduced those of GSDME (0.94±0.05
vs
1.35±0.10
0.52±0.03
vs
1.20±0.06
P
<
0.05) when compared with the cells from the OGD/R group.
Conclusion
2
OGD/R can induce pyroptosis and apoptosis in A549 cells simultaneously
and there exists shared signaling pathway in pyroptosis and apoptosis. Pyroptosis and apoptosis inhibitors can simultaneously inhibit the 2 types of OGD/R-induced cell death.
关键词
Keywords
references
DENG Y X, HOU L, XU Q Y, et al . Cardiopulmonary bypass induces acute lung injury via the high-mobility group box 1/toll-like receptor 4 pathway[J ] . Dis Markers, 2020, 2020: 8854700. DOI:10.1155/2020/8854700.
KARACALILAR M, ONAN I S, ONAN B, et al . Effects of pulmonary perfusion during cardiopulmonary bypass on lung functions after cardiac operation[J ] . J Card Surg, 2020, 35(10): 2469-2476. DOI:10.1111/jocs.14934.
YUAN S M. Postperfusion lung syndrome: physiopathology and therapeutic options[J]. Rev Bras Cir Cardiovasc, 2014, 29(3): 414-425. DOI:10.5935/1678-9741.20140071.
HU Z Z, YUAN Y, ZHANG X L, et al . Human umbilical cord mesenchymal stem cell-derived exosomes attenuate oxygen-glucose deprivation/reperfusion-induced microglial pyroptosis by promoting FOXO3a-dependent mitophagy[J ] . Oxid Med Cell Longev, 2021, 2021: 6219715. DOI:10.1155/2021/6219715.
XIE P, REN Z K, LV J, et al . Berberine ameliorates oxygen-glucose deprivation/reperfusion-induced apoptosis by inhibiting endoplasmic Reticulum stress and autophagy in PC12 cells[J ] . Curr Med Sci, 2020, 40(6): 1047-1056. DOI:10.1007/s11596-020-2286-x.
SHI J J, GAO W Q, SHAO F. Pyroptosis: gasdermin-mediated programmed necrotic cell death[J]. Trends Biochem Sci, 2017, 42(4): 245-254. DOI:10.1016/j.tibs.2016.10.004.
WANG Q, WU J F, ZENG Y C, et al . Pyroptosis: a pro-inflammatory type of cell death in cardiovascular disease[J ] . Clin Chim Acta, 2020, 510: 62-72. DOI:10.1016/j.cca.2020.06.044.
MCKENZIE B A, DIXIT V M, POWER C. Fiery cell death: pyroptosis in the central nervous system[J]. Trends Neurosci, 2020, 43(1): 55-73. DOI:10.1016/j.tins.2019.11.005.
XU X B, LAI Y Y, HUA Z C. Apoptosis and apoptotic body: disease message and therapeutic target potentials[J]. Biosci Rep, 2019, 39(1): BSR20180992. DOI:10.1042/BSR20180992.
KACZANOWSKI S. Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging[J]. Phys Biol, 2016, 13(3): 031001. DOI:10.1088/1478-3975/13/3/031001.
WANG X Y, XIAO Z Y, YI H, et al . Effects of oxygen-glucose deprivation/recovery on pyroptosis of A549 alveolar epithelial cells[J ] . Chin J Cell Biol, 2020, 42(11): 1969-1974.
MAN S M, KARKI R, KANNEGANTI T D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases[J]. Immunol Rev, 2017, 277(1): 61-75. DOI:10.1111/imr.12534.
MAHIB M R, HOSOJIMA S, KUSHIYAMA H, et al . Caspase-7 mediates caspase-1-induced apoptosis independently of bid[J ] . Microbiol Immunol, 2020, 64(2): 143-152. DOI:10.1111/1348-0421.12756.
RIGO A, FERRARINI I, LORENZETTO E, et al . BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes[J ] . Cell Death Dis, 2019, 10(12): 889. DOI:10.1038/s41419-019-2126-8.
ORNING P, LIEN E, FITZGERALD K A. Gasdermins and their role in immunity and inflammation[J]. J Exp Med, 2019, 216(11): 2453-2465. DOI:10.1084/jem.20190545.
RUAN J W, WANG S J, WANG J B. Mechanism and regulation of pyroptosis-mediated in cancer cell death[J]. Chem Biol Interact, 2020, 323: 109052. DOI:10.1016/j.cbi.2020.109052.
WANG Y P, GAO W Q, SHI X Y, et al . Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J ] . Nature, 2017, 547(7661): 99-103. DOI:10.1038/nature22393.
ALI A, CYPEL M. Commentary: To Die or not to Die-rescuing lung cells from ischemia-reperfusion injury[J]. J Thorac Cardiovasc Surg, 2022, 163(2): e123-e124. DOI:10.1016/j.jtcvs.2021.01.091.
LAGIER D, FISCHER F, FORNIER W, et al . Effect of open-lung vs conventional perioperative ventilation strategies on postoperative pulmonary complications after on-pump cardiac surgery: the PROVECS randomized clinical trial[J ] . Intens Care Med, 2019, 45(10): 1401-1412. DOI:10.1007/s00134-019-05741-8..